Holen Sie sich die Stockscreener-App
19.62
0.86%
-0.17
Handel nachbörslich:
19.30
-0.32
-1.63%
Finanzdaten der Viridian Therapeutics Inc-Aktie (VRDN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
0.00%
0.072
|
0.072 | 0.072 | 0.072 | 0.098 |
| Operating Expenses |
21.78%
55.97
|
71.55 | 51.30 | 59.35 | 72.57 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
21.78%
55.97
|
71.55 | 51.30 | 59.35 | 72.57 |
| Operating Income/Loss |
21.80%
-55.90
|
-71.48 | -51.22 | -59.27 | -72.47 |
| Nonoperating Income/Loss |
59.27%
7.355
|
4.618 | 3.564 | 4.212 | 4.322 |
| Income/Loss From Continuing Operations Before Tax |
0.00%
0.072
|
0.072 | 0.072 | -55.06 | -68.15 |
| Income/Loss From Continuing Operations After Tax |
27.40%
-48.54
|
-66.86 | -47.66 | -55.06 | -68.15 |
Net Income/Loss
|
27.40%
-48.54
|
-66.86 | -47.66 | -55.06 | -68.15 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,499%
61.10
|
1.6978 | 43.65 | 43.25 | 42.24 |
| Diluted Average Shares |
3,499%
61.10
|
1.6978 | 43.65 | 43.25 | 42.24 |
| Basic Earnings Per Share |
41.04%
-0.79
|
-1.34 | -1.09 | -1.27 | -1.61 |
| Diluted Earnings Per Share |
41.04%
-0.79
|
-1.34 | -1.09 | -1.27 | -1.61 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):